XML 34 R27.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2024
Share-based Payment Arrangement [Abstract]  
Summary of Stock Option Transations

The following table summarizes the stock option transactions for the 2023 Plan:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Options

 

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term (years)

 

 

 

Aggregate Intrinsic Value (in thousands)

 

Outstanding at December 31, 2023

 

 

1,739,270

 

 

$

 

15.71

 

 

 

6.99

 

 

$

 

76

 

Granted

 

 

1,226,500

 

 

 

 

4.17

 

 

 

9.69

 

 

 

 

330

 

Exercised

 

 

(12,852

)

 

 

 

1.55

 

 

 

 

 

 

 

 

Cancelled

 

 

(228,475

)

 

 

 

75.27

 

 

 

 

 

 

 

 

Outstanding at September 30, 2024

 

 

2,724,443

 

 

$

 

5.58

 

 

 

8.35

 

 

$

 

1,280

 

Vested and exercisable at September 30, 2024

 

 

1,192,485

 

 

$

 

6.63

 

 

 

7.11

 

 

$

 

540

 

Schedule of Assumptions Using Black-Scholes to Estimate Fair Value of the stock option grants

The following are the underlying assumptions in Black-Scholes to determine the fair value of the stock option grants for the nine months ended September 30, 2024 and 2023:

 

 

 

Nine Months Ended September 30,

 

 

2024

 

2023

Risk free interest rate

 

3.11%

 

3.50%-3.56%

Expected volatility

 

96%

 

75%-76%

Expected term (years)

 

6.01

 

6.25

Expected dividend yield

 

0%

 

0%

Summary of Stock-Based Compensation Expense Recognized for Options and RSUs Granted

Stock-based compensation expense recognized for options and restricted stock units granted was as follows (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Research and development

 

$

273

 

 

$

184

 

 

$

634

 

 

$

2,426

 

General and administrative

 

 

508

 

 

 

298

 

 

 

1,047

 

 

 

9,645

 

Total stock-based compensation expense

 

$

781

 

 

$

482

 

 

$

1,681

 

 

$

12,071

 

Schedule of Common Stock Reserved for Future issuance

Common stock reserved for future issuance consists of the following at September 30, 2024:

 

 

 

September 30,

 

 

 

2024

 

Common stock warrants

 

 

3,352,621

 

Stock options issued and outstanding

 

 

2,724,443

 

Shares available for issuance under the 2023 Plan

 

 

948,049

 

Shares available under the 2023 ESPP

 

 

122,545

 

Total

 

 

7,147,658